Ticker Scorecard - FOLD Basics Company: Amicus Therapeutics, Inc. IPO Date: May 31, 2007 Sector: Healthcare Industry: Biotech Market Cap: $2.93B Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 2.69% Avg Daily Range (30 D): $0.13 | 1.37% Avg Daily Range (90 D): $0.18 | 1.67% Institutional Daily Volume Avg Daily Volume: 1.44M Avg Daily Volume (30 D): 1.87M Avg Daily Volume (90 D): 1.92M Trade Size Avg Trade Size (Sh.): 148 Avg Trade Size (Sh.) (30 D): 117 Avg Trade Size (Sh.) (90 D): 109 Institutional Trades Total Inst.Trades: 6,983 Avg Inst. Trade: $2.89M Avg Inst. Trade (30 D): $3.78M Avg Inst. Trade (90 D): $2.6M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.57M Avg Closing Trade (30 D): $4.11M Avg Closing Trade (90 D): $4.05M Avg Closing Volume: 308.16K     News Jan 2, 2025 @ 12:00 PM Amicus Therapeutics to Present at the 43rd Annual ... Source: N/A Nov 15, 2024 @ 11:00 AM Protein Therapeutics Market Size to be Worth USD 5... Source: Transparency Market Research, Inc. Nov 1, 2024 @ 11:00 AM Amicus Therapeutics to Present at Upcoming Investo... Source: N/A Oct 17, 2024 @ 5:44 PM Alnylam Stock Up on Cardiomyopathy Drug Regulatory... Source: Zacks Oct 17, 2024 @ 11:00 AM Amicus Therapeutics Announces Settlement of Galafo... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.34 $-.02 $-.05 Diluted EPS $-.34 $-.02 $-.05 Revenue $ 493.67M $ 141.52M $ 126.67M Gross Profit $ 444.24M $ 128.24M $ 115.41M Net Income / Loss $ -104.69M $ -6.73M $ -15.7M Operating Income / Loss $ 5.21M $ 21.66M $ 14.97M Cost of Revenue $ 49.43M $ 13.28M $ 11.26M Net Cash Flow $ -29.45M $ 24.46M $ -.44M PE Ratio